Jessica M.J. Rhee, MD, MS

Jessica M.J. Rhee, MD, MS

For all patient related matters: Phone: (808) 586-5854 | Fax: (808) 586-5857
This email address is being protected from spambots. You need JavaScript enabled to view it. | (808) 564-3999

Medical Director, Clinical Trials Office, University of Hawaiʻi Cancer Center
Core Clinical Member, Translational and Clinical Research, University of Hawaiʻi Cancer Center

Academic Appointment(s):
Associate Professor (Researcher), University of Hawaiʻi Cancer Center, University of Hawaiʻi at Mānoa
Associate Professor, Department of Medicine, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa

Degree(s):
MS, Biochemistry & Molecular Biology, University of Chicago, Chicago, IL
MD, University of Illinois at Chicago College of Medicine, Chicago, IL
Internal Medicine Residency, University of California Irvine, Orange, CA
Hematology/Oncology Fellowship, University of California Irvine, Orange, CA

Research Focus

Dr. Rhee joined the University of Hawaiʻi Cancer Center in August 2017. As Medical Director of the Clinical Trials Office (CTO), she oversees the CTO activities that support clinical and translational research which include investigator initiated, government sponsored and industry sponsored clinical trials.

Dr. Rhee's clinical practice in both community and academic settings has focused on women with breast cancer and those at high risk. She also has a specific interest in breast cancer survivorship to help survivors optimize their health and wellness during and after treatment.

Selected Publications

Le H, Ziogas A, Rhee JMM, Lee JG, Lipkin SM, Zell JA. (2008). A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. Cancer Epidemiol Biomarkers Prev;17(10):2737–41.

Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. (2007). Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev;16:546-552.

Karpova, AY, Abe MK, Li J, Liu PT, Rhee JM, Kuo WL, Hershenson MB. (1997). MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. Am J Physiology;272:L558-565.

Kuo WL, Abe MK, Rhee JM, Eves EM, McCarthy SA, Yen M, Templeton DJ, McMahon M, Rosner MR. (1996). Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol Cell Biol;16:1458-1470.

Publication list via PubMed